HOME >> MEDICINE >> NEWS
Experimental shingles vaccine proves effective in nationwide study

In one of the largest adult vaccine clinical trials ever, researchers have found that an experimental vaccine against shingles (zoster vaccine) prevented about half of cases of shingles--a painful nerve and skin infection--and dramatically reduced its severity and complications in vaccinated persons who got the disease. The findings appear in the June 2 issue of The New England Journal of Medicine.

The Shingles Prevention Study, conducted over 5 -years, was led by the Department of Veterans Affairs (VA) and carried out in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and Merck & Co., Inc. (Whitehouse Station, NJ).

"This is very promising news for older persons," says Stephen E. Straus, M.D., an infectious diseases specialist at NIAID and Director of the NIH National Center for Complementary and Alternative Medicine, who participated in the design, oversight and conduct of the trial. "These striking results indicate for the first time that we can use a vaccine to prevent shingles, one of the most common and debilitating illnesses of aging. And among vaccine recipients who did get shingles, the episodes generally were far milder than they otherwise would have been."

"For some people, shingles can result in months or even years of misery," comments study leader Michael N. Oxman, M.D., an infectious disease specialist at the San Diego VA Healthcare System and the University of California, San Diego.

Shingles, also known as herpes zoster, is caused by reactivation of the virus that causes chickenpox. Once chickenpox infection has run its course, the virus is not eliminated; rather, it retreats to clusters of sensory nerve cells usually located near the spinal cord, where the virus persists in a dormant state. As immunity weakens with advancing age, the virus can reactivate, multiply in and damage sensory nerve cells to cause pain. It then migrates
'"/>

Contact: Laurie K. Doepel
doepel@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
1-Jun-2005


Page: 1 2 3 4

Related medicine news :

1. Experimental gene therapy abolishes arthritis pain and lessens joint damage
2. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
3. Experimental flu vaccine appears promising in early tests
4. Experimental ragweed therapy offers allergy sufferers longer relief with fewer shots
5. Experimental medication kicks depression in hours instead of weeks
6. Experimental vaccine protects lab animals against several strains of H5N1
7. Experimental therapies and vaccines for Ebola and Marburg viruses focus of Academy meeting
8. Tai Chi boosts immunity to shingles virus in older adults, NIH-sponsored study reports
9. Antiviral drugs may help relieve nerve pain related to shingles
10. Epidural injection does not reduce long-term pain for people with shingles
11. Traditional Chinese exercises may increase efficacy of flu vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Health & Safety Institute ... and HAZWOPER 8-, 24- and 40-Hour courses from now until November 30, 2017 to ... to offering these discounted prices to all businesses and government agencies – whether or ...
(Date:9/20/2017)... ... 2017 , ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in ... 11, off work and rolled up their sleeves to help with relief efforts. The ... start the process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment ...
(Date:9/20/2017)... ... September 20, 2017 , ... “They Sang At Her Funeral”: a tale ... starts revealing the skeletons in their closets. “They Sang At Her Funeral” is the ... years young and married with five children and twelve grandchildren. Before becoming a writer, ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... on St. Vincent’s Infusion Services called, “PAPA Healthcare helps fill gaps, provide essential ... Services enhanced service delivery and operations by leveraging PAPA Healthcare’s post-acute productivity and ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... the winners of the Entrepreneur Innovation Awards (EIA), held this past Thursday night ... are Connecticut-based companies and entrepreneurs, presented their innovative project ideas to a panel ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017 NuvoAir (formerly called ... announced today a partnership with Novartis Pharma AG to distribute ... position as the leading mobile spirometry platform and Novartis, commitment ... ... ...
(Date:9/6/2017)... Sept. 6, 2017  Robert G. Szewc, M.D., is ... Member in recognition of his contributions to the Medical ... a Nephrologist at the practice of Kidney and Hypertension ... care and hypertension solutions. He has worked in this ... career experience, as well as expertise in kidneys, hypertension, ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology:
Cached News: